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Abstract
Context—Although maternal stature has been associated with offspring mortality and health, the
extent to which this association is universal across developing countries is unclear.
Objective—To examine the association between maternal stature and offspring mortality,
underweight, stunting, and wasting in infancy and early childhood in 54 low- to middle-income
countries.
Design, Setting, and Participants—Analysis of 109 Demographic and Health Surveys in 54
countries conducted between 1991 and 2008. Study population consisted of a nationally
representative cross-sectional sample of children aged 0 to 59 months born to mothers aged 15 to
49 years. Sample sizes were 2 661 519 (mortality), 587 096 (underweight), 558 347 (stunting), and
568 609 (wasting) children.
Main Outcome Measures—Likelihood of mortality, underweight, stunting, or wasting in
children younger than 5 years.
Results—The mean response rate across surveys in the mortality data set was 92.8%. In adjusted
models, a 1-cm increase in maternal height was associated with a decreased risk of child mortality
(absolute risk difference [ARD], 0.0014; relative risk [RR], 0.988; 95% confidence interval [CI],
0.987–0.988), underweight (ARD, 0.0068; RR, 0.968; 95% CI, 0.968–0.969), stunting (ARD,
0.0126; RR, 0.968; 95% CI, 0.967–0.968), and wasting (ARD, 0.0005; RR, 0.994; 95% CI, 0.993–
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0.995). Absolute risk of dying among children born to the tallest mothers (≥160 cm) was 0.073
(95% CI, 0.072–0.074) and to those born to the shortest mothers (<145 cm) was 0.128 (95% CI,
0.126–0.130). Country-specific decrease in the risk for child mortality associated with a 1-cm
increase in maternal height varied between 0.978 and 1.011, with the decreased risk being
statistically significant in 46 of 54 countries (85%) (α=.05).
Conclusion—Among 54 low- to middle-income countries, maternal stature was inversely
associated with offspring mortality, underweight, and stunting in infancy and childhood.
Maternal stature is an important determinant of intrauterine growth restriction1 and low birth
weight,2 birth weight and intrauterine growth restriction are predictors of subsequent
mortality and growth failure.3 Because attained height reflects the health stock accumulated
through social and environmental exposures during early childhood,4,5 maternal stature is a
simple, stable, and useful marker for assessing intergenerational linkages in health. Maternal
stature has been shown to predict offspring outcomes before or immediately after birth.6
However, evidence for whether risks associated with shorter maternal stature have a lasting
influence on the offspring’s health during infancy and childhood is limited, or is restricted to
small nonrepresentative samples, and inconclusive. In a large, nationally representative data
set from India, an inverse association between maternal stature and both child mortality and
growth failure was observed.7 It remains unclear the extent to which this association is
present across a wider range of countries. Using the largest available, nationally
representative, and comparable sample from 109 surveys in 54 low- to middle-income
countries, with objective measurements of maternal stature and offspring anthropometry, we
investigated the potential long-term effects of maternal stature on offspring mortality,
underweight, stunting, and wasting in infancy and early childhood.
METHODS
Data Sources
Data for this study came from 109 Demographic and Health Surveys (DHS) conducted in 54
low-to middle-income countries between 1991 and 2008 (Table 1).8 The DHS are nationally
representative household sample surveys measuring indicators of population, health, and
nutrition, with special emphasis on maternal and child health.9 The target population in most
DHS surveys was all women (or in some cases ever-married women)of reproductive age
(15–49 years). A complete birth and death history was collected for each eligible woman’s
children, including date of birth and when applicable age at death of each child.
Anthropometric measurements on children were restricted to children born 5 years or less
before the survey and alive at the time of the survey.9 Trained investigators weighed each
child with a solar-powered scale accurate to within 100 g; maternal and child height were
measured using an adjustable board calibrated in millimeters and theoretically accurate to 1
mm.10
Due to coverage, comparability, and data quality, DHS is the primary reliable data source
for measuring child mortality and undernutrition across developing countries.11–13 The DHS
uses extensive interviewer training, standardized measurement tools and techniques, an
identical core questionnaire, and instrument pretesting to ensure standardization and
comparability across diverse sites and time.10 Teams responsible for data collection are
monitored during fieldwork, including spot-checking and validation of completed
questionnaires.10 Country reports detail pretesting and quality assurance measures by survey
(see http://www.measuredhs.com/pubs/browse_type.cfm). The DHS is modular in structure,
comprising a core questionnaire, a set of country-relevant modules, and country-specific
variables. The DHS provides data with standardized variables across surveys and imputed
dates of key events (see http://www.measuredhs.com/pubs/pdf/DHSG4/Recode4DHS.pdf).
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The DHS uses a multistage stratified design with probabilistic sampling with each
elementary unit having a defined probability of selection.14 Every survey was stratified by
urban and rural status and additionally by country-specific geographic or administrative
regions. eTable 1 (available at http://www.jama.com) describes each survey by country and
year, along with sampling characteristics, response rates, and sample sizes. Detailed
sampling plans are available from survey final reports at
http://www.measuredhs.com/pubs/browse_type.cfm.
Study Population and Sample Size
For the pooled mortality analysis, the study population consisted of all children (n=3 395
212) born to mothers (n = 939 140) aged 15 to 49 years (eTable 2). There were 635 709
children (19%) whose mother’s height was intentionally not measured (eTable 1 shows
height measurement protocol by survey). Among children whose mother’s height should
have been measured, 92 839 (3%) did not have a height measure in the data; these cases
were excluded. We also excluded children whose mothers had recorded heights of less than
100 cm or more than 200 cm, as these were considered improbable or outliers. Furthermore,
children who had missing information on the covariates included in this analysis (n = 5145,
<1%) were excluded. The final analytical sample for the mortality analysis was 2 661 519
children born to 751 912 mothers surveyed between 1991 and 2008 in 54 low- to middle-
income countries (eTable 2).
For the anthropometric analysis, the study population comprised children (n=829 680) born
3 to 5 years preceding the survey to mothers (n=342 229) aged 15 to 49 years and alive at
the time of the survey (eTable 3). There were 71 155 children (9% of the children sample)
for whom maternal height was intentionally not measured. Among children whose mother’s
height should have been measured, 23 677 (3%) did not have a height measure in the data
and an additional 59 941 (8%) were missing data on covariates. In addition, 116 560
children (15%) had missing or biologically implausible height, 87 811 children (12%) had
missing or biologically implausible weight, and 106 298 children (14%) had missing or
biologically implausible weight for height. The World Health Organization (WHO) cutoffs
for biological implausibility were used (eTable 3).15 The final analytical samples for the
anthropometric analysis were 587 096 children born to 247 279 mothers for underweight,
558 347 children born to 234 604 mothers for stunting, and 568 609 children born to 239
628 mothers for wasting surveyed between 1991 and 2008 in 54 low- to middle-income
countries (eTable 3).
Outcomes, Exposure, and Covariates
Offspring mortality was a binary variable; 1 if the child died between 0 to 59 months and 0
otherwise. Mortality by age categories was also assessed (<1 month [neonates], 1–11
months [infants], and 12–59 months [children]). Each variable was binary; 1 if the child died
during that age interval and 0 otherwise. The risk set was all children alive at the beginning
of the interval and the event was death during the interval.
Growth failure was defined as underweight, stunting, or wasting.3 Underweight z scores
were calculated by subtracting from a child’s weight the median weight for a child of that
age and sex and dividing by the SD of the weight for a child of that age and sex in the WHO
reference population15; stunting was measured by subtracting from a child’s height the
median height for a child of that age and sex and dividing by the SD of the height for a child
of that age and sex in the WHO reference population15; and wasting was measured by
subtracting from a child’s weight the median weight for a child of that height and sex and
dividing by the SD of the weight for a child of that height and sex in the WHO reference
population15 (see http://www.who.int/childgrowth/standards/en/). Software used for z score
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calculations is available at http://www.who.int/childgrowth/software/en/. Growth failure was
defined as more than 2 SDs under WHO-growth standards15 on each dimension separately.
We also calculated severe growth failure, defined as more than 3 SDs under WHO-growth
standards.15
Maternal height was specified as a continuous and a categorical exposure with the following
cutpoints: less than 145 cm, 145 to 149.9 cm, 150 to 154.9 cm, 155 to 159.9 cm, and 160.0
cm or more.
Sex, birth order, birth interval, birth year, and twin status of the child; mother’s age at birth
of the child, education, occupation, and marital status; and household wealth and urban or
rural residence were included as covariates (Table 2). Household wealth was defined in
terms of ownership of material possessions,16 with each child assigned a wealth score based
on a combination of different household characteristics that were weighted according to a
factor analysis procedure. For this procedure, z scores were calculated for each indicator
variable and a principal components analysis was performed using these z scores. For each
household, the values of the indicator variables were multiplied by the factor loadings and
summed to produce a standardized household index value with a mean of 0 and an SD of 1.
This standardized score was then divided into quintiles for each country.17,18 In addition, we
also derived an overall wealth quintile that was comparable across countries, based on assets
common across surveys, which included whether the household had electricity, radio, or
bicycle, and by major source of drinking water. We conducted a factor analysis on these 5
assets, using principal components analysis, and derived overall wealth quintiles.
Analysis
Individual country files were created, combining multiple survey years, ensuring
consistency of variable definitions across various survey years as well as consistency of
region and primary sampling unit identifiers. These individual files were concatenated for
the pooled analysis. Because prevalence of outcomes were more than 10%, we used a
modified Poisson approach with robust error variance to model the binary outcomes
associated with mortality and growth failure.19 We also estimated stratified models for
neonates (<1 month), infants (1–11 months), and children (12–59 months) after testing for
an interaction between maternal height and child’s age. We also conducted an analysis by
child age for the anthropometric analysis. Results are presented as change in risks (relative
to 1) for a 1-cm change in maternal height and, when maternal height is specified as
categories, we report both the relative risks (RRs) and absolute probabilities. Absolute risk
differences were calculated by fitting a normal model with an identity link.20 We also
provided the absolute risk differences for maternal height categories calculated as
differences in the absolute probabilities between the different maternal height categories
compared with mothers in the tallest category. We accounted for clustering of children by
mothers and primary sampling units in all analyses and included country and birth year fixed
effects in pooled analyses. Country heterogeneity in the association between maternal
stature and offspring outcomes were tested using Wald tests. Models were estimated by
using STATA version 10SE.21 Statistical precision was ascertained by using 2-tailed Wald
tests and exact P values, except when P<.05 are reported. Several ex-Soviet Republics had
small numbers of respondents and events in the lowest education categories. For mortality
analysis, education was not included for Kyrgyz Republic and education was included as a
continuous variable in growth failure analysis for Kyrgyz Republic, Kazakhstan,
Uzbekistan, and Moldova.
We conducted the following sensitivity analyses. First, to test for nonlinearity in the effect
of maternal height and the appropriateness of the height categories, we conducted analyses
with alternate categorizations of height. The analyses were also repeated removing the
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extreme (top and bottom 1%) outliers of maternal height. Second, in some populations with
very early child-bearing, height could be affected by childbearing, which itself is associated
with higher mortality risks. We conducted analysis restricted to women who had their first
child after the age of 20 years. Third, because several of the study covariates were measured
contemporaneously, a reduced form model, including only variables likely to be determined
before the outcome (ie, age of mother at birth, education, and year-born), was estimated.
Fourth, we estimated the pooled model without India, which comprised 15.4% of the total
sample size, and where an association between maternal height and offspring mortality and
growth failure has been shown.7 Fifth, given issues related to relative vs absolute wealth, we
estimated pooled models with and without the global wealth index. Sixth, to test for recall
bias in mortality, we conducted analysis restricted to births in the last 5 years preceding the
survey. Seventh, because the survey period varies between 1991 and 2008, we tested if the
main results hold in a restricted sample of countries surveyed after 2000. In addition, we
compared prevalence of mortality, underweight, stunting, and wasting among women who
did and did not report height, as well as comparing maternal heights among children who
did and did not report child anthropometric measures as sensitivity tests for missing
information.
Ethical Review
The DHS data collection procedures were approved by the ORC Macro (Calverton,
Maryland) institutional review board as well as by the relevant body in each country that
approves research studies on human subjects. Oral informed consent for the interview or
survey was obtained from respondents by interviewers. This analysis was reviewed by the
Harvard School of Public Health Institutional Review Board and was considered exempt
from full review because the study was based on an anonymous public use data set with no
identifiable information on the survey participants.
RESULTS
Mortality
The mean response rate across surveys in the mortality data set was 92.8%, ranging from
75.1% in Brazil (1996) to 98.8% in Egypt (2008) (eTable 1). The sample size was 2 661 519
for child mortality analysis, ranging from 3770 children in Comoros to 482 378 children in
India (Table 1). Of 2 661 519 children in the data set, 312 553 died between the ages of 0 to
59 months, with a mortality prevalence of 11.7% (95% confidence interval [CI],
11.7%-11.8%) (Table 1). The prevalence of child mortality varied between 3.3% (Jordan)
and 24.7% (Niger). Results are reported by country in an interactive information graphic
(see http://www.jama.com). The covariate distribution across categories of maternal height
was largely overlapping (eTable 4), although there were imbalances for location (70.4%
rural for <145 cm vs 64.3% for >160 cm), local wealth quintile (31.9% in poorest quintile
for <145 cm vs 20.4% for >160 cm), twin (1.3% prevalence of twins for <145 cm vs 3.0%
for >160 cm), occupation (55.0% working for <145 cm vs 64.3% for >160 cm), and
education (14.8% secondary or higher education for <145 cm vs 25.1% for >160 cm).
In the pooled analysis, a 1-cm increase in maternal height was associated with a decreased
risk in offspring mortality in unadjusted(RR,0.983;95%CI,0.982–0.984)and adjusted(RR,
0.988;95%CI, 0.987–0.988) models (Table 3). In adjusted models, compared with the tallest
mothers (≥160 cm), each lower height category had substantially higher risk of child
mortality, with children born to mothers of height shorter than 145 cm having an increased
RR of 1.397(95% CI,1.373–1.422). The absolute probability of dying among children born
to the tallest mothers (≥160 cm) was 0.073 (95%CI,0.072–0.074)and among those children
born to the shortest mothers (<145 cm), absolute probability was 0.128 (95% CI, 0.126–
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0.130). The association between maternal height and offspring mortality was strongest
among neonates (RR, 0.982; 95% CI, 0.981–0.983), followed by infants aged 1 to 11
months (RR, 0.988; 95% CI, 0.987–0.989) and weakest for children aged 12 to 59 months
(RR, 0.990; 95% CI, 0.989–0.992).
Country-specific risk of mortality by age 5 years for a 1-cm increase in maternal height
ranged between 0.978 (95% CI, 0.964–0.992) for Kyrgyz Republic and 1.011 (95% CI,
0.996–1.026; P=.14) for Comoros. Mortality risk associated with increased height was
decreased in 52 of 54 countries (96%) (ie, <1) and was statistically significant in 46 of those
54 countries (85%) (α=.05) (Figure 1). A joint Wald test of country-specific coefficients
rejected the null hypothesis of equivalence, suggesting heterogeneity in the strength of the
association between maternal height and offspring mortality across countries (χ2=165.37,
P<.001) (eTable 5). The association between maternal height and offspring mortality
remained among country groupings based on the World Bank income classification and
WHO geographic regions (Figure 2).
Growth Failure
The sample size for the anthropometric analysis was 587 096, 558 347, and 568 609 children
for underweight, stunting, and wasting, respectively; with sample sizes varying from 944 to
68 597 children for underweight, 897 to 64 028 children for stunting, and 924 to 65 487
children for wasting, in Comoros and India, respectively (Table 1). Of children in the
sample, 21.5% were underweight (95% CI, 21.4%-21.6%), 38.3% were stunted (95% CI,
38.2%-38.5%), and 8.9% had wasting (95% CI, 8.8%-9.0%). The prevalence of underweight
varied from 3.4% for Armenia to 44.5% for Bangladesh; stunting from 10.7% for Moldova
to 55.2% for Ethiopia; and wasting from 1.3% for Honduras to 19.7% for India (Table 1).
Results are reported by country in an interactive information graphic (see
http://www.jama.com). The covariate distribution across categories of maternal height in the
anthropometric data set was largely overlapping across covariates (eTable 6), and the
patterns were similar to those reported earlier for the mortality data set.
In pooled adjusted models, a 1-cm increase in height was associated with a decreased risk in
underweight (RR, 0.968; 95% CI, 0.968–0.969), stunting (RR, 0.968; 95% CI, 0.967–0.968),
and wasting (RR, 0.994; 95% CI, 0.993–0.995) (Table 4). Compared with the tallest mothers
(≥160 cm), each lower height category had substantially higher risk of offspring
underweight and stunting, with the risk being highest for mothers shorter than 145 cm.
Analysis stratified by child’s age showed no differential effect for underweight and stunting
(eTable 7). An association was also observed between maternal height and severe growth
failure (eTable 8). The RR for underweight, for a 1-cm increase in height, ranged from 0.930
(95% CI, 0.922–0.939) for Colombia to 0.991 (95% CI, 0.968–1.015; P=.40) for
Uzbekistan, and was statistically significant in 50 of 54 countries (93%) (eFigure 1). For a 1-
cm increase in height, the risk of stunting ranged from 0.926 (95% CI, 0.921–0.931) for
Colombia to 0.993 (95% CI, 0.977–1.009; P=.39) for Azerbaijan, and was statistically
significant in 52 of 54 countries (96%) (eFigure 2). The association between maternal height
and wasting was weak and was statistically significant in only 11 of 54 countries (20%)
(eFigure 3).
Sensitivity Analysis
We examined if there were substantial differences in the prevalence of mortality,
underweight, stunting, and wasting among women who did and did not report maternal
height, and observed considerable overlap in the prevalence distribution (eTable 9). No
differences were found in maternal height among children who were measured and not
measured for height or weight (eTable 10). The main results on mortality and growth failure
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appeared to be robust to sensitivity tests that included removing outliers, specifying maternal
height in various ways to test for nonlinearity, excluding India from the overall analysis,
restricting the analysis to mothers whose first born was after age 20 years, using overall
wealth quintile, restricting the analysis to births in the last 5 years, restricting the analysis to
surveys conducted after 2000, and to conditioning the association on only exogenous
variables (eTable 7 and eTable 11). eTable 12 shows the mutually adjusted association
between maternal height, select covariates and child mortality, underweight, stunting, and
wasting.
COMMENT
Using large representative samples of children and mothers from 54 low-to middle-income
countries, we observed a robust inverse association between maternal height and child
mortality, underweight, and stunting. Our finding is suggestive of the importance of early
life factors, not only for the subsequent health of a woman (as reflected in her attained
stature)but also to her offspring’s health, and highlights the long-term effects of mother’s
poor health stock. The weak association between wasting and maternal height may be
because wasting reflects acute growth failure and is more likely to be influenced by
contemporaneous factors as opposed to long-term effects of maternal health.
The association of maternal height and offspring health has a biomechanical plausibility (ie,
shorter women have narrower pelves that increase the likelihood of cephalopelvic
disproportion and obstructed labor)22,23 and a biological plausibility (ie, in shorter mothers
who may have lower health stock, the supply of nutrients to the fetus may be inadequate,
leading to intrauterine growth restriction and low birth weight, which can influence
offspring health and survival).24 For mothers, limited nutrient supply at the cellular level
during their development may lead to maintenance of basic metabolic functions taking
precedence and resources being diverted away from growth, resulting in growth retardation
and shortened stature.25 Furthermore, inflammation caused by infections has deleterious
long-term health consequences,26 which may be transmitted to offspring. Because attained
adult height reflects the stressful nutritional environment of the mother in early life,27 a
plausible interpretation of an association between maternal stature and offspring health also
reflects the intergenerational transfer of socioeconomic adversity.
Our study relies on DHS data that in general are considered to be of high quality and are
often the only source of maternal and child health surveillance in developing countries.28
The comparability of the DHS data across countries and time, achieved through use of
standardized questionnaires, manuals, field procedures, and technical support makes these
data particularly appropriate for our study.28 Not-withstanding the strengths of the DHS
data, recall bias in reporting offspring birth and death histories remains a potential
concern.29 Furthermore, clustering of the age at death, particularly at 12 months, was a
concern in country samples from sub-Saharan Africa.30 Despite objective measurements, a
quality analysis of height data in 81 DHS surveys also showed clustering on whole and half
centimeters, with some additional heaping at multiples of 5 and 10 cm.13 However, with the
exception of Guatemala (1998–1999) and Bolivia (1994), the low levels of missing or
implausible heights in almost all DHS surveys are taken as evidence that the quality of the
recorded data be considered acceptable.13
The study findings should also be interpreted alongside the following caveats. First, the
association between maternal height and offspring mortality, underweight, and stunting
could arise due to unobserved factors common to both mother and child. Second, data
constraints did not allow us to study how maternal height and child health are associated;
restricting our assessment to whether there is an association and the extent to which it is
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common. Third, because women who may have died in childbirth are not observed, this
could potentially lead to sampling bias in that causes of child mortality are linked to causes
of maternal mortality with such women having a different covariate profile than those
surviving. Fourth, contemporaneously measured covariates do not necessarily reflect the
same covariates at the time of death of the child. In addition, although we show effect
estimates pooled across countries, the assessment of the presence of an association between
maternal height and offspring mortality, underweight, and stunting should be based on the
consistency of the association in each country included in this study.
Our findings help resolve the mixed and inconclusive evidence observed in small
nonrepresentative samples in a limited set of countries on the association between maternal
height and child survival, with some suggesting a protective effect,31–35 while others show a
null or reverse association.36–41 Besides confirming the overall inverse association between
maternal stature and child mortality,42 our findings show that in more than 90% of the
countries studied, children of shorter mothers were more likely to die, with robust
association across different categories of country-level income as well as geographic
regions. The consistent inverse association (both overall and country-specific) between
maternal stature and child underweight and stunting is also novel as previous studies have
been restricted to few countries, with small samples, and assessments of maternal stature
largely restricted to childhood stunting.43–46
In conclusion, our study provides evidence that shorter maternal stature is a risk factor for
offspring mortality, underweight, and stunting in developing countries. Underscoring the
policy significance of this association, for child mortality, the effect of being in the lowest
height category (relative to the tallest) was approximately 70% and 80% of the size of the
effect of having no education or being in the poorest income quintile, respectively. For
childhood underweight and stunting, maternal height was the most important factor, with an
effect size about twice that of being in the lowest education category and 1.5 times that of
being in the poorest quintile. This suggests the presence of an intergenerational transmission
from mother’s own nutrition, disease, and socioeconomic circumstances during her
childhood to her offspring’s health and mortality in their infancy and childhood.
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Figure 1.
Country-Specific Adjusted Change in Offspring Mortality Risks for 1-cm Increase in
Maternal Height Among Children Younger Than 5 Years
Plotted on log scale; error bars are 95% confidence intervals (CIs). Wald test for equivalence
of coefficients rejected (χ2=165.37, P<.001). See eTable 5 for relative risks and CIs by
country. Tanzania refers to the United Republic of Tanzania and Guinea refers to the
Republic of Guinea. An interactive information graphic is available at
http://www.jama.com.
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Figure 2.
Box Plots of Relative Risk for the Association Between 1-cm Increase in Maternal Height
and Offspring Mortality Among Children by World Bank Income Classification and WHO
Regional Classification of Countries
WHO, World Health Organization; IQR, interquartile range. Plotted on log scale. For World
Bank income classification, low income indicates $975 or less; lower middle income, $976–
$3855; upper middle income, $3856–$11 905 (2008) gross national income per capita.
Boxes indicate first and third quartiles with median lines; whiskers indicate first quartile
minus 1.5 × IQR and third quartile + 1.5 × IQR; all values outside the whiskers are shown as
filled circles (outliers). An interactive information graphic is available at
http://www.jama.com.
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Table 2
Frequency and Percentage Distribution of Child Mortality, Underweight, Stunting, and Wasting by Maternal,
Child, and Household Covariates
Covariates
No. (%) of Participants
Mortality (n = 2 661 519) Underweight (n = 587 096) Stunting (n = 558 347) Wasting (n = 568 609)
Maternal
Height, cm (continuous)a 156 (7.2) 156 (7.2) 156 (7.2) 156 (7.2)
 ≥160 715 535 (26.9) 165 204 (28.1) 156 769 (28.1) 159 329 (28.0)
 155–159.9 687 642 (25.8) 154 596 (26.3) 147 145 (26.4) 149 809 (26.4)
 150–154.9 673 568 (25.3) 145 513 (24.8) 138 793 (24.9) 141 488 (24.9)
 145–149.9 413 693 (15.5) 86 152 (14.7) 81 958 (14.7) 83 554 (14.7)
 <145 171 081 (6.4) 35 631 (6.1) 33 682 (6.0) 34 429 (6.1)
Age at birth, y
 <17 142 278 (5.4) 18 298 (3.1) 17 313 (3.1) 17 598 (3.1)
 17–19 459 614 (17.3) 77 784 (13.3) 73 910 (13.2) 75 287 (13.2)
 20–24 920 332 (34.6) 178 853 (30.5) 170 068 (30.5) 173 275 (30.5)
 25–29 631 531 (23.7) 145 305 (24.8) 138 218 (24.8) 140 769 (24.8)
 ≥30 507 764 (19.1) 166 856 (28.4) 158 838 (28.5) 161 680 (28.4)
Occupation
 Not working 1 060 981 (39.9) 254 963 (43.4) 241 091 (43.2) 245 702 (43.2)
 Working 1 600 538 (60.1) 332 133 (56.6) 317 256 (56.8) 322 907 (56.8)
Marital status
 Unmarried 277 426 (10.4) 48 564 (8.3) 46 569 (8.3) 47 479 (8.4)
 Married 2 383 957 (89.6) 538 532 (91.7) 511 778 (91.7) 521 130 (91.7)
Education
 None 1 210 905 (45.5) 222 711 (37.9) 210 012 (37.6) 213 951 (37.6)
 Primary 826 169 (31.0) 195 808 (33.4) 187 303 (33.6) 190 684 (33.5)
 Secondary or higher 624 445 (23.5) 168 577 (28.7) 161 032 (28.8) 163 974 (28.8)
Child
Birth order
 First 711 464 (26.7) 140 849 (24.0) 133 852 (24.0) 136 375 (24.0)
 Second 598 027 (22.5) 124 371 (21.2) 118 356 (21.2) 120 423 (21.2)
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Covariates
No. (%) of Participants
Mortality (n = 2 661 519) Underweight (n = 587 096) Stunting (n = 558 347) Wasting (n = 568 609)
 Third 444 918 (16.7) 93 834 (16.0) 89 288 (16.0) 90 990 (16.0)
 Fourth 311 953 (11.7) 68 186 (11.6) 64 843 (11.6) 66 052 (11.6)
 ≥Fifth 595 157 (22.4) 159 856 (27.2) 152 008 (27.2) 154 769 (27.2)
Birth interval, mo
 First child 711 464 (26.7) 140 849 (24.0) 133 852 (24.0) 136 375 (24.0)
 <24 620 528 (23.3) 93 492 (15.9) 89 025 (16.0) 90 442 (15.9)
 24–47 1 010 360 (38.0) 244 749 (41.7) 232 686 (41.7) 237 041 (41.7)
 ≥48 318 600 (12.0) 107 879 (18.4) 102 663 (18.4) 104 630 (18.4)
Sex
 Male 1 359 296 (51.1) 297 401 (50.7) 282 643 (50.6) 288 102 (50.7)
 Female 1 302 223 (48.9) 289 695 (49.3) 275 704 (49.4) 280 507 (49.3)
Twin
 Not twin 2 602 444 (97.8) 575 164 (98.0) 547 150 (98.0) 557 160 (98.0)
 Twin 59 075 (2.2) 11 932 (2.0) 11 197 (2.0) 11 449 (2.0)
Age category, mo
 <1 112 930 (4.3) 3443 (0.6) 3512 (0.6) 5800 (1.0)
 1–12 240 838 (9.1) 124 139 (21.8) 113 721 (20.4) 122 105 (20.8)
 >12 2 285 369 (86.9) 441 027 (77.6) 441 114 (79.0) 459 191 (78.2)
Age, moa 22 (17.7) 28 (16.9) 28 (16.9) 28 (16.8)
Household
Wealth quintile, within country
 First, poorest 620 912 (23.3) 140 794 (24.0) 133 539 (23.9) 136 085 (23.9)
 Second 566 230 (21.3) 125 884 (21.4) 119 808 (21.5) 121 941 (21.5)
 Third 538 283 (20.2) 118 173 (20.1) 112 369 (20.1) 114 475 (20.1)
 Fourth 498 194 (18.7) 108 144 (18.4) 103 069 (18.5) 104 962 (18.5)
 Fifth, richest 437 900 (16.5) 94 101 (16.0) 89 562 (16.0) 91 146 (16.0)
Location
 Urban 911 435 (34.2) 204 156 (34.8) 195 229 (35.0) 198 620 (34.9)
 Rural 1 750 084 (65.8) 382 940 (65.2) 363 118 (65.0) 369 989 (65.1)
a
Continuous height and child age are reported as mean (SD).
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